Aberfoyle Park, Australia

Keat-Chye Cheah

This inventor holds 1 USPTO granted patent. Top assignee: Breasagen Limited. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keat-Chye Cheah. Retrieved from https://idiyas.com/inventor/keat-chye-cheah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Keat-Chye Cheah

Introduction

Keat-Chye Cheah is an accomplished inventor based in Aberfoyle Park, Australia. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents.

Latest Patents

One of his notable patents is titled "Haemopoietic growth factor antagonists and uses therefor." This invention relates to variant recombinant forms of haemopoietic growth factors that serve as antagonists to their native counterparts. These variants are useful in ameliorating the aberrant effects caused by the native molecules and have applications in the treatment of tumors, cancers, and inflammation. Keat-Chye Cheah holds 1 patent in this area.

Career Highlights

Keat-Chye Cheah is associated with Breasagen Limited, a company that focuses on innovative biotechnological solutions. His work has contributed to advancements in medical treatments and therapeutic strategies.

Collaborations

Throughout his career, he has collaborated with notable colleagues, including Angel Francisco Lopez and Mary Francis Shannon. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Keat-Chye Cheah's contributions to the field of biomedical research through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of critical health issues, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…